Trial intelligence / Profile preview

Annarazole sodium vs rabeprazole sodium in duodenal ulcer

CTR20192626Phase 3Completed

Sponsor
Xuanzhu Biopharmaceutical
Start
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of anaprazole sodium in duodenal ulcer, sponsored by Xuanzhu Biopharmaceutical. Started Dec 2019; status: completed.

02

Drugs

anaprazole sodium
03

Conditions

duodenal ulcer

Beyond the preview

Go deeper on CTR20192626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20192626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call